# A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

> **NCT02954094** · — · ACTIVE_NOT_RECRUITING · sponsor: **Target PharmaSolutions, Inc.** · enrollment: 10000 (estimated)

## Conditions studied

- Hepatocellular Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02954094
- **Lead sponsor:** Target PharmaSolutions, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-12
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 10000 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02954094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02954094, "A Longitudinal Observational Study of the Natural History and Management of Patients With HCC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02954094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*